Browsing Tag
Euronext Brussels
6 posts
Fagron (EBR: FAGR) posts 23% Q3 growth as IV bag recovery becomes the test
Fagron delivered €281.3 million of Q3 revenue and reaffirmed FY2026 guidance, but acquisition contributions widened the gap between headline and organic growth while an industry-wide IV bag recall constrained North American compounding volumes.
CMB.TECH targets cleaner shipping growth after Q2 profit reaches $364m
CMB.TECH Q2 profit hit $364M as tanker rates surged, vessel sales added $127M and backlog held at $3.26B.
Umicore raises 2026 profit outlook as critical metals offset EV battery weakness
Umicore EBITDA rose 34% to €577 million as recycling and cobalt profits grew, while battery earnings relied on take-or-pay contracts.
Why argenx is buying Forte Biosciences before FB102 enters its bigger proof stage
argenx agrees to buy Forte Biosciences for $2.2 billion. Read how FB102 could reduce Vyvgart concentration risk and reshape ARGX’s autoimmune strategy.
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
UCB is acquiring Neurona for up to $1.15 billion to deepen its epilepsy pipeline. Read what the deal means for growth, risk, and biotech competition.
Ecobat divests French lead facilities to Campine in move to sharpen lithium-ion recycling focus
Ecobat sells its French lead operations to Campine NV, reshaping Europe’s recycling sector and signaling a strategic pivot toward lithium-ion growth.